Clinical Trials Directory

Trials / Completed

CompletedNCT04518254

Contribution of L-Tyrosine to Human Decision Making in Stressful Situations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

L-tyrosine is a chemical precursor of dopamine. Under specific conditions, tyrosine administration can increase brain dopamine levels and therefore several studies have explored whether tyrosine supplementation can have a beneficial effect on cognitive and behavioural performance that is dependent on dopaminergic function. However, the effects of tyrosine supplementation are mixed: some studies show positive effects while others do not. Stress leads to an increase in dopaminergic activity and turnover in the brain, resulting in a decrease in brain dopamine levels. We propose to study the contribution of tyrosine to decision making and more particularly to the processes of response selection (mediated by the prefrontal cortex and under the influence of the dopaminergic system) in stressful situations.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood collectionA blood sample will be collected before and after treatment administration
DRUGL-Tyrosine 500 MgThe participants will be administered 4 capsules of L-Tyrosine 500 mg per oral route
DRUGPlaceboThe participants will be administered 4 capsules of Lactose 500 mg (placebo) per oral route
BEHAVIORALCognitive tasksThe participants will perform cognitive decision-making tasks: Simon task and masking task after treatment administration
OTHERStress exposureUnpleasant but not painful skin stimulations will be administered to the participants at variable intervals on the left leg during the cognitive tasks
BEHAVIORALAnxiety scaleSpielberger's State Trait Anxiety Inventory (STAI) will be filled by the participants before and after cognitive tasks
DEVICEElectromyography (EMG)Electromyography measurements will be performed during cognitive tasks.
DEVICEElectroencephalography (EEG)Electroencephalography measurements will be performed during cognitive tasks.

Timeline

Start date
2021-11-18
Primary completion
2022-04-07
Completion
2022-04-07
First posted
2020-08-19
Last updated
2022-11-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04518254. Inclusion in this directory is not an endorsement.